Boom or Bust? VAPE HOLDINGS INC(VAPE), Kingfisher plc (KGFHY) and Anthera Pharmaceuticals Inc(ANTH)

Posted by Saimoon February 12, 2015 0 Comment 1536 views


New York, NY – GDP INSIDER  –  02/12/2015.

This article discusses three companies: VAPE HOLDINGS INC(OTCMKTS:VAPE), Kingfisher plc (ADR)(OTCMKTS:KGFHY) and  Anthera Pharmaceuticals Inc(NASDAQ:ANTH)

VAPE HOLDINGS INC(OTCMKTS:VAPE) is a specialist in the legal cannabis industry and its stock still has not recovered from the massive devaluation in its stock in March last year after FINRA issued a warning about marijuana stocks causing the price to drop from over $40 a share to less than $1. Despite this, Vape shares continue to be actively traded and rose 2.24% to $0.685 on volume of just under 50,000 shares traded. Vape quick ratio is at 0.18 and has negative EPS so unless marijuana becomes more widely available the price is unlikely to break $1.

Will Things Continue Looking Bleak For VAPE HOLDINGS INC Or Will Things Continue To Rise? Discover The Potential Risks And Rewards On VAPE With Our Free Analysis.

Kingfisher plc (ADR)(OTCMKTS:KGFHY) the home improvement retailer based in the UK has been experiencing a steadily decline in its value dropping from a high of $14.85 six months ago to close down 0.91% yesterday at $10.30. Kingfisher plc has been selling off underperforming assets around the globe and focusing on its core business. With a forward P/E of 14.71, EPS of 0.76 and a quick ratio of 0.48, the company has reasonable fundamentals but the 1 year estimate for the share price is $8.79 indicating it may still have further to fall.

When Should You Consider Investing In Kingfisher plc? Delve Into The Details And Find Out Everything You Need To Know To Invest With Our Free Analysis.

Anthera Pharmaceuticals Inc(NASDAQ:ANTH) is a biopharmaceutical company focused on developing treatments for life threatening diseases. Anthera Pharmaceuticals Inc announced yesterday that it had successfully completed the interim Phase 3 trials of its new Lupus treatment drug, Blisibimod, which boosted the share price 25%. The rally continued yesterday with the stock closing up another 16.31% at $3.78 with 7.7 million shares traded, far above the 3 month average of 627,000. The stock should correct downwards but has now broken through the $2.60 resistance and could be a good medium to long term investment as the trials continue successfully.

Should You Place Your Pennies In Anthera Pharmaceuticals Inc? Know All The Facts Before You Invest, Click Here For Our Free ANTH Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

 


Write Your Comment